Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2794045rdf:typepubmed:Citationlld:pubmed
pubmed-article:2794045lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2794045lifeskim:mentionsumls-concept:C0017661lld:lifeskim
pubmed-article:2794045lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:2794045lifeskim:mentionsumls-concept:C0021017lld:lifeskim
pubmed-article:2794045lifeskim:mentionsumls-concept:C0042200lld:lifeskim
pubmed-article:2794045lifeskim:mentionsumls-concept:C1155229lld:lifeskim
pubmed-article:2794045lifeskim:mentionsumls-concept:C0456389lld:lifeskim
pubmed-article:2794045lifeskim:mentionsumls-concept:C1704711lld:lifeskim
pubmed-article:2794045lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:2794045lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:2794045pubmed:issue4lld:pubmed
pubmed-article:2794045pubmed:dateCreated1989-11-1lld:pubmed
pubmed-article:2794045pubmed:abstractTextPrimary IgA nephropathy (IgAN) is characterized by mesangial deposits of IgA1, increased serum IgA1 levels, and circulating immune complexes containing predominantly IgA1. It has previously been found that patients with IgAN have a higher than normal IgA response to vaccination, but the IgA subclasses have not been studied. To investigate whether the IgA hyperresponsiveness is limited to the subclass IgA1, which is involved in the pathogenesis of IgAN, we compared the immune responses of 18 patients with 22 healthy controls after intramuscular vaccination with inactivated influenza virus. Antibody titers were significantly higher (P less than 0.0001) for the IgA1 subclass in patients versus controls, but not for the other isotypes. A substantial portion of the IgA and IgA1 antiinfluenza immune response comprised polymers in both patients and controls. There was no preferential response of polymers in patients. Patients produced significantly more monomeric IgA1 antibodies than controls. These results show that patients with IgAN have a hyperresponsiveness limited to the subclass IgA1 and mainly expressed by an excess of monomers.lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:languageenglld:pubmed
pubmed-article:2794045pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2794045pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2794045pubmed:statusMEDLINElld:pubmed
pubmed-article:2794045pubmed:monthOctlld:pubmed
pubmed-article:2794045pubmed:issn0021-9738lld:pubmed
pubmed-article:2794045pubmed:authorpubmed-author:HermannMMlld:pubmed
pubmed-article:2794045pubmed:authorpubmed-author:MasurelNNlld:pubmed
pubmed-article:2794045pubmed:authorpubmed-author:GageA PAPlld:pubmed
pubmed-article:2794045pubmed:authorpubmed-author:van EsL ALAlld:pubmed
pubmed-article:2794045pubmed:authorpubmed-author:BeyerW EWElld:pubmed
pubmed-article:2794045pubmed:authorpubmed-author:Evers-Schoute...lld:pubmed
pubmed-article:2794045pubmed:authorpubmed-author:van den...lld:pubmed
pubmed-article:2794045pubmed:issnTypePrintlld:pubmed
pubmed-article:2794045pubmed:volume84lld:pubmed
pubmed-article:2794045pubmed:ownerNLMlld:pubmed
pubmed-article:2794045pubmed:authorsCompleteYlld:pubmed
pubmed-article:2794045pubmed:pagination1070-5lld:pubmed
pubmed-article:2794045pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:meshHeadingpubmed-meshheading:2794045-...lld:pubmed
pubmed-article:2794045pubmed:year1989lld:pubmed
pubmed-article:2794045pubmed:articleTitleHumoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.lld:pubmed
pubmed-article:2794045pubmed:affiliationDepartment of Nephrology, University Hospital, Leiden, The Netherlands.lld:pubmed
pubmed-article:2794045pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2794045pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed